GE Healthcare, VUMC join on cancer immunotherapy research
GE Healthcare and Vanderbilt University Medical Center will collaborate on enabling safer and more precise treatment of cancer immunotherapies. Under the during the five-year program, the organizations will analyze the immunotherapy treatment response of thousands of VUMC cancer patients by using anonymized demographic, genomic, tumor, cellular, proteomic and imaging data. Cancer immunotherapy is a treatment… Read More »